The application of transgenic (knockout) technology to the study of pain is
rapidly expanding. Despite its power, this technique has several shortcomi
ngs that complicate the interpretation of the data obtained. Although compe
nsation by other genes is a well recognized problem, issues related to the
background genotype of the mutant mice are less well appreciated. This revi
ew describes these confounds as they apply to studies of pain and pain inhi
bition. We show that the 129 and C57BL/6 mouse strains, which provide the d
efault genetic background on which null mutants are constructed, display si
gnificant and sometimes extreme phenotypic differences in many assays of no
ciception, hypersensitivity, and analgesia. Although problems related to th
e differential responsiveness of the two strains are minimized by placing k
nockouts onto "pure" 129 and/or C57BL/6 backgrounds, we also illustrate tha
t neither of these strains are particularly representative of inbred mice i
n general. Procedures to reduce confounds and converging evidence must be u
sed to accurately determine the functions of the targeted genes in pain-rel
ated phenomena.